PHAXIAM Therapeutics S.A. Euronext Paris
Equities
PHXM
FR0011471135
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 EUR | +1.20% | 0.00% | -35.87% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.25% | 104B | |
+1.55% | 97.42B | |
+0.79% | 22.2B | |
-17.80% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-16.87% | 15.06B | |
+3.44% | 13.98B | |
+33.90% | 11.66B |
- Stock Market
- Equities
- PHXM Stock
- PHXM Stock
- News PHAXIAM Therapeutics S.A.
- Erytech Pharma Secures US Patent in Methioninase, Asparaginase Use for Solid Tumors -- Stock up 3% After-Hours